Consolidated Statements of Operations and Comprehensive Income - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue:
Total revenue	$ 120,385,274	$ 112,749,380
Expenses:
Total expenses	105,703,079	92,454,250
Operating income	14,682,195	20,295,130
Finance expense	6,609,618	4,567,327
Gain from equity investment	(1,766,968)
Income before tax	9,839,545	15,727,803
Income tax expense	1,627,061	2,711,886
Net and comprehensive income	8,212,484	13,015,917
Attributable to:
Shareholders of the Company	3,771,163	4,679,921
Non-controlling interest	4,441,321	8,335,996
Net and comprehensive income	$ 8,212,484	$ 13,015,917
Earnings per share attributable to shareholders
Basic	$ 0.053	$ 0.064
Diluted	$ 0.052	$ 0.063
Weighted average shares outstanding:
Basic	71,536,310	72,582,733
Diluted	72,697,539	74,085,172
Anesthesia Services [Member]
Revenue:
Total revenue	$ 110,306,431	$ 101,790,165
Expenses:
Total expenses	94,506,039	81,079,150
Product [Member]
Revenue:
Total revenue	10,078,843	10,959,215
Expenses:
Total expenses	4,647,719	5,022,737
Corporate Expense [Member]
Expenses:
Total expenses	$ 6,549,321	$ 6,352,363